23andMe, a genetic testing company, is bought by a nonprofit led by its co-founder for $305 million.

23andMe, a genetic testing company, has been sold to TTAM Research Institute, a nonprofit led by 23andMe co-founder Anne Wojcicki, for $305 million. The sale, approved by a U.S. bankruptcy court, includes 23andMe's genetic services and Lemonaid Health. TTAM promises to uphold 23andMe's privacy policies and enhance data protection for customers. This comes after 23andMe faced challenges including a data breach and board resignations.